Boston Scientific Corp. PT Raised to $15.00 at Cowen and Company (BSX)
Equities researchers at Cowen and Company boosted their price target on shares of Boston Scientific Corp. (NYSE:BSX) from $14.00 to $15.00 in a research report issued on Friday, ARN reports. Cowen and Company’s target price would indicate a potential upside of 10.86% from the stock’s previous close.
Other equities research analysts have also recently issued reports about the stock. Analysts at Piper Jaffray upgraded shares of Boston Scientific Corp. from a “neutral” rating to an “overweight” rating in a research note to investors on Tuesday, January 21st. They now have a $18.00 price target on the stock, up previously from $12.00. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Boston Scientific Corp. in a research note to investors on Tuesday, January 14th. They now have a $14.00 price target on the stock. Finally, analysts at Barclays raised their price target on shares of Boston Scientific Corp. from $13.00 to $14.00 in a research note to investors on Thursday, January 9th. They now have an “overweight” rating on the stock. Eleven investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. Boston Scientific Corp. currently has an average rating of “Hold” and an average target price of $12.22.
Boston Scientific Corp. (NYSE:BSX) traded down 0.22% on Friday, hitting $13.53. The stock had a trading volume of 14,001,031 shares. Boston Scientific Corp. has a 52 week low of $7.07 and a 52 week high of $14.08. The stock’s 50-day moving average is $12.63 and its 200-day moving average is $11.72. The company’s market cap is $18.066 billion. Boston Scientific Corp. also was the recipient of unusually large options trading activity on Tuesday. Stock investors bought 11,136 put options on the stock. This is an increase of 455% compared to the average volume of 2,005 put options.
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.